We are live on ! Find out more
PODD icon

Insulet

266 hedge funds and large institutions have $6.87B invested in Insulet in 2019 Q1 according to their latest regulatory filings, with 70 funds opening new positions, 103 increasing their positions, 66 reducing their positions, and 25 closing their positions.

New
Increased
Maintained
Reduced
Closed

180% more first-time investments, than exits

New positions opened: 70 | Existing positions closed: 25

67% more funds holding in top 10

Funds holding in top 10: 35 (+2)

56% more repeat investments, than reductions

Existing positions increased: 103 | Existing positions reduced: 66

24% more capital invested

Capital invested by funds: $5.54B → $6.87B (+$1.34B)

20% more funds holding

Funds holding: 221266 (+45)

3.45% more ownership

Funds ownership: 118.32%121.77% (+3.4%)

1% more call options, than puts

Call options by funds: $26.4M | Put options by funds: $26M

Holders
266
Holders Change
+45
Holders Change %
+20.36%
% of All Funds
5.76%
Holding in Top 10
5
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+66.67%
% of All Funds
0.11%
New
70
Increased
103
Reduced
66
Closed
25
Calls
$26.4M
Puts
$26M
Net Calls
+$344K
Net Calls Change
-$3.55M

PODD Hedge Fund Activity: Q1 2019 in Review

266 of the 4,620 institutional investors tracked by Wall St. Rank reported a position in Insulet (PODD) for Q1 2019, worth a combined $6.87B — up 24% from $5.54B a quarter earlier.

Buyers outnumbered sellers: 70 funds opened new PODD positions and 25 closed out — a net gain of 45 holders — while 103 added to existing stakes and 66 trimmed.

The largest buyer was Capital Research Global Investors, adding an estimated $83.8M. The largest seller was D1 Capital Partners, exiting entirely with an estimated $133M sold.

  • 266 institutional investors held Insulet (PODD) as of Q1 2019, up from 221 in Q4 2018.
  • Funds reported $6.87B of Insulet stock for Q1 2019, up 24% quarter-over-quarter.
  • 70 funds opened new Insulet positions in Q1 2019 and 25 closed out, a net change of +45 holders.
  • The largest Insulet buyer in Q1 2019 was Capital Research Global Investors, an estimated $83.8M added.
  • The largest Insulet seller in Q1 2019 was D1 Capital Partners, an estimated $133M sold.

Based on aggregated 13F filings for Q1 2019.